COMMUNIQUÉS West-GlobeNewswire

Bavarian Nordic Announces Initiation of Phase 2 Trial Evaluating the Combination Therapy of CV301 and Nivolumab in Metastatic Colorectal Cancer
11/07/2018
Investigator-led study has commenced dosing Immunotherapy candidate CV301 is being assessed in combination with checkpoint inhibitors in multiple solid tumors COPENHAGEN, Denmark, July 11, 2018 - Bavarian Nordic A/S ( [...]
Wright Medical Group N.V. to Host Second Quarter 2018 Earnings Conference Call
11/07/2018
Wednesday, August 8, 2018, at 3:30 p.m. Central / 4:30 p.m. Eastern AMSTERDAM, The Netherlands, July 11, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ:WMGI) today announced that it will host a conference [...]
Wright Medical Group N.V. Highlights Significant New Product Launches at the American Orthopaedic Foot & Ankle Society (AOFAS) 2018 Annual Meeting
11/07/2018
Company Announces U.S. Launch of PROstep™ Minimally Invasive Surgery System Company Initiates U.S. Commercial Distribution and Sale of AUGMENT ® Injectable Bone Graft AMSTERDAM, The Netherlands, July 11, 2018 (GLOBE [...]
Leading Commercial and Transactional Healthcare Executive Shawn Cline Tomasello Joins Mesoblast Board
11/07/2018
NEW YORK and MELBOURNE, Australia, July 11, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that Shawn Cline Tomasello has joined its Board of Directors. With more than 30 years’ [...]
Virbac : bilan semestriel contrat de liquidité au 30 juin 2018
11/07/2018
Carros, le 10 juillet 2018 BILAN SEMESTRIEL DES MOYENS ALLOUES AU CONTRAT DE LIQUIDITE Au titre du contrat de liquidité confié par la société VIRBAC S.A. à la société EXANE BNP PARIBAS, les moyens suivants figuraient au [...]
Shire plc : Rule 2.9 Announcement
11/07/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 11 July 2018 Shire [...]
Idorsia successfully completes the offering of new shares and the offering of convertible bonds thereby securing long-term funding for the development of its advancing pipeline
11/07/2018
NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, ITALY, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATON OR DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAWS [...]
Achaogen to Host Investor Lunch Updating Investors on Commercial Strategy Post FDA Approval of Plazomicin on July 12th in New York City
10/07/2018
― Key opinion leaders Steven Burdette, M.D., ( Professor of Medicine at Wright State University Boonshoft School of Medicine) and Joshua Rosenberg, M.D. (Chair of Critical Care at The Brooklyn Hospital Center) to [...]
Assure Holdings Corp. Announces Update
10/07/2018
PARKER, Colo., July 10, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV:IOM) (OTCQB:ARHH) is providing an update relating to the appointment of its new auditor and an update relating [...]
Reata Receives Orphan Drug Designation from the European Commission for Omaveloxolone for the Treatment of Friedreich’s Ataxia
10/07/2018
IRVING, Texas, July 10, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA), a clinical-stage biopharmaceutical company, today announced that the European Commission has granted orphan drug designation [...]
CytomX Therapeutics Announces Proposed Public Offering of Common Stock
10/07/2018
SOUTH SAN FRANCISCO, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/07/2018
MENLO PARK, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Idera Pharmaceuticals Announces Termination of Merger Agreement with BioCryst Pharmaceuticals
10/07/2018
EXTON, Pa., July 10, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) announced today that the Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) entered into by and among Idera [...]
Assembly Biosciences Announces Proposed Underwritten Offering of Common Stock
10/07/2018
INDIANAPOLIS and SAN FRANCISCO, July 10, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq:ASMB) (“Assembly”), today announced that it intends to offer and sell, subject to market and other conditions, 3,000, [...]
Athersys to Host Second Quarter Financial Results Call
10/07/2018
CLEVELAND, July 10, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) will release its second quarter 2018 financial results at approximately 4:00 PM Eastern Time on Tuesday, August 7 th , 2018, and will host a [...]
Bespoke Extracts Signs Agreement With Seidman Food Brokerage To Market Bespoke’s Hemp-Derived CBD Products to 1500 Food Stores Throughout the Southeastern U.S. and the Caribbean
10/07/2018
SUNNY ISLES, Fla., July 10, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTC Pink:BSPK), producer of high quality, great tasting, hemp-derived CBD extract products, today announced that it has signed an agreement [...]
HealthEC Announces New Chronic Care Management Partnerships
10/07/2018
Practices Cite Optimized Reimbursements, Quick System Implementation and Simple Platform Navigation as Key Reasons for Joining Growing List of HealthEC’s CCM Customers EDISON, N.J., July 10, 2018 (GLOBE NEWSWIRE) -- [...]
How to Treat Minor Cuts; American Academy of Dermatology
10/07/2018
ROSEMONT, Ill., July 10, 2018 (GLOBE NEWSWIRE) -- Cuts from a sharp knife or a piece of glass are very common. They often occur while people are preparing food, washing dishes or even crafting. All it takes is a slip of [...]
CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social
10/07/2018
Communiqué de Presse Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 10 juillet 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]

Pages